NasdaqHealth CarePharmaceutical PreparationsLONDON, ENGLAND, United Kingdom

Tiziana Life Sciences Ltd TLSA

Ask your AI

Estimated market cap $68.68M120.51M shares, shares as of Dec 31, 2025CIK 1723069

Insider trades, 12 mo

5 buys · 0 sells

$1.04M bought, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

6 added · 7 trimmed

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

What changed in Tiziana Life Sciences Ltd's latest quarterly report, compared with the one before.

We have not read a recent 10-Q for this company yet.

Insider trades

5 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Aug 5, 2026. Insiders have two business days to file.

Recent insider trades

Gabriele M. Cerrone Director, 10% owner	Jul 21 Form 4/A ↗	Buy	+$41.9K 42,357 sh @ $0.99	-43.8%
Gabriele M. Cerrone Director, 10% owner	Jun 12 Form 4/A ↗	Buy	+$16.6K 15,000 sh @ $1.11	-49.9%
Ivor Elrifi Chief Executive Officer	Aug 5 Form 4 ↗	Buy	+$237.6K 237,616 sh @ $1.00	-40.4%
Ivor Elrifi Chief Executive Officer	Aug 4 Form 4 ↗	Buy	+$81.3K 83,807 sh @ $0.97	-38.9%
Ivor Elrifi Chief Executive Officer	Aug 3 Form 4 ↗	Buy	+$667.0K 667,000 sh @ $1.00	-40.8%

All TLSA insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

2.72M shares

22 funds report TLSA. Values checked against market prices.

Funds own 2.0% of shares (Q2 2026)

32 funds hold the stock.

Q3 2026: 2.3% · 5,560 of ~8,900 funds reported so far

Q2 20253.8%
Q3 20253.4%
Q4 20252.5%
Q1 20262.6%
Q2 20262.0%
Q3 2026 (so far)2.3%

Q3 2026. 2 new, 6 added to, 7 trimmed, 11 exited since Q2 2026.

Top 13F holders
#
1	Marshall Wace, LLP 13F ↗	1.18M	$1.3M	New
2	Renaissance Technologies LLC 13F ↗	500,133	$555.1K	+3717.8%
3	Mid-American Wealth Advisory Group, Inc. 13F ↗	448,667	$498.0K	+38.8%
4	Zhang Financial LLC 13F ↗	140,350	$155.8K	+11.4%
5	Jane Street Group, LLC 13F ↗	120,816	$134.1K	+775.9%
6	Focus Partners Wealth 13F ↗	79,365	$88.1K	unchanged
7	Morgan Stanley 13F ↗	53,656	$59.6K	unchanged
8	China Universal Asset Management Co., Ltd. 13F ↗	50,000	$47.7K	+177.8%
9	Geode Capital Management, LLC 13F ↗	35,968	$39.9K	-54.0%
10	Rachor Investment Advisory Services, LLC 13F ↗	17,000	$18.9K	unchanged

Download CSV Every fund that holds TLSA, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Tiziana Life Sciences Ltd and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Tiziana Life Sciences Ltd and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q4 2021	23	—	5.86M	$5.7M
Q1 2022	23	0	5.73M	$6.0M
Q2 2022	24	+1	5.33M	$4.0M
Q3 2022	25	+1	5.33M	$4.1M
Q4 2022	23	-2	5.28M	$3.2M
Q1 2023	18	-5	1.08M	$1.2M
Q2 2023	20	+2	871,213	$596.8K
Q3 2023	24	+4	788,273	$521.9K
Q4 2023	21	-3	918,394	$512.9K
Q1 2024	20	-1	1.07M	$488.3K
Q2 2024	25	+5	924,120	$850.1K
Q3 2024	30	+5	1.94M	$1.8M
Q4 2024	33	+3	1.00M	$698.3K
Q1 2025	33	0	3.00M	$3.3M
Q2 2025	31	-2	4.56M	$4.0M
Q3 2025	32	+1	4.04M	$8.7M
Q4 2025	34	+2	3.03M	$3.2M
Q1 2026	33	-1	3.14M	$3.7M
Q2 2026	32	-1	2.43M	$3.1M
Q3 2026	22	-10	2.72M	$3.0M

Each point is a quarter-end, from Q4 2021 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (G88912103). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q4 2021) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes1 in 12 mo 8-K eventsNone in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials3 active IPO history2 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Tiziana Life Sciences Ltd
Address: 3RD FLOOR, 11-12 ST. JAMES'S SQUARE, LONDON, ENGLAND, United Kingdom SW1Y 4LB
Phone: 0044(0) 207-495-2379
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer
Incorporated in: Bermuda
Listed as: TLSA (Nasdaq)
Former names: Tiziana Life Sciences plc (until 2021)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$0.5699−$0.04 (−6.65%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $0.5699 · High $1.09Nov 13, 2026

Aug 13, 2026Low $0.5699 · High $1.19Nov 13, 2026

Nov 13, 2025Low $0.5699 · High $1.82Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.